Guided Therapeutics (GTHP) Operating Leases (2019 - 2025)
Guided Therapeutics recorded quarterly Operating Leases of $651000.0 in Q4 2025, up 756.58% quarter-over-quarter from $76000.0 in Q3 2025, and up 320.0% year-over-year from $155000.0 in Q4 2024.
Guided Therapeutics' Operating Leases history runs 7 years deep, the most recent figure standing at $651000.0 for Q4 2025.
- In Q4 2025, Operating Leases rose 320.0% year-over-year to $651000.0; the TTM figure through Dec 2025 stood at $651000.0 (up 320.0% YoY), while the FY2025 annual figure was $651000.0, up 320.0% from the prior year.
- Operating Leases came in at $651000.0 for Q4 2025 at Guided Therapeutics, up from $76000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $651000.0 in Q4 2025 to a low of $377.0 in Q1 2022.
- A 5-year average of $264388.3 and a median of $267000.0 in 2022 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases slumped 99.9% in 2022 and soared 59581.7% in 2023, its largest moves.
- Guided Therapeutics' Operating Leases stood at $325000.0 in 2021, then changed by 0.0% to $325000.0 in 2022, then decreased by 24.31% to $246000.0 in 2023, then plunged by 36.99% to $155000.0 in 2024, then surged by 320.0% to $651000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $651000.0, $76000.0, and $130000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 651,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Sep 30, 2024 | 178,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Sep 30, 2023 | 267,000.00 |
| Jun 30, 2023 | 287,000.00 |
| Mar 31, 2023 | 225,000.00 |
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 267,000.00 |
| Jun 30, 2022 | 360,000.00 |
| Mar 31, 2022 | 377.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 407,000.00 |
| Jun 30, 2021 | 419,000.00 |
| Mar 31, 2021 | 376,000.00 |
| Dec 31, 2020 | 392,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Dec 31, 2019 | 29,000.00 |
| Sep 30, 2019 | 66,000.00 |
| Jun 30, 2019 | 72,000.00 |
| Mar 31, 2019 | 97,000.00 |